Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELUTIA INC. Director's Dealing 2020

Oct 8, 2020

34697_dirs_2020-10-07_58a1fb39-71f2-4015-879c-6de2d7534abb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AZIYO BIOLOGICS, INC. (AZYO)
CIK: 0001708527
Period of Report: 2020-10-07

Reporting Person: Ferguson Matthew (Chief Financial Officer)